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Abstract
The Type VI secretion system (T6SS) is a bacterial nanomachine which delivers toxic effectors 
to kill competitors or subvert some of their key functions. Here we use transposon directed 
insertion-site sequencing (TraDIS) to identify T6SS toxins associated with the H1-T6SS, one 
of the three T6SS machines found in Pseudomonas aeruginosa. This approach identified several 
putative toxin-immunity pairs, including Tse8-Tsi8. Full characterization of this protein pair 
demonstrated that Tse8 is delivered by the VgrG1a spike complex into prey cells where it targets 
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the transamidosome, a multiprotein complex involved in protein synthesis in bacteria that lack 
either one, or both, of the asparagine and glutamine tRNA synthases. Biochemical characterization 
of the interactions between Tse8 and the transamidosome components GatA, GatB and GatC 
suggests that the presence of Tse8 alters the fine-tuned stoichiometry of the transamidosome 
complex, and in vivo assays demonstrate that Tse8 limits the ability of prey cells to synthesize 
proteins. These data expand the range of cellular components targeted by the T6SS by identifying 
a T6SS toxin affecting protein synthesis proteins and validate the use of a TraDIS-based global 
genomics approach to expand the repertoire of T6SS toxins in T6SS-encoding bacteria.
Bacteria rarely exist in a single-species planktonic state and instead form complex 
polymicrobial structures, called biofilms1,2. Within this context bacteria often compete with 
other microorganisms to secure space and nutrients. The Type VI secretion system (T6SS) is 
a Gram-negative bacterial nanomachine that delivers toxins into neighbouring competitors to 
either kill or subvert their key functions in order to attain dominance within a given niche3–5. 
The T6SS is composed of 13 core components, several of which are structurally related to 
proteins from the T4 bacteriophage tail6. The Hcp tube-like structure is capped by a VgrG­
PAAR tip complex, or spike, and encapsulated within a TssBC (also known as VipAB) 
contractile sheath 7–9. Upon extension of the sheath within the cytoplasm and subsequent 
contraction, the spike is thought to facilitate the puncturing of the cell membranes of both 
the producing and target cells, allowing delivery of the attached toxins8,10. T6SS toxins 
have been shown to be secreted in association with the VgrG tip complex, the Hcp tube, or 
as extension domains of the VgrG, PAAR or Hcp proteins11–14. Importantly, neighbouring 
bacterial sister cells are protected from the effects of the toxins by production of cognate 
immunity proteins, which are usually encoded adjacent to the toxin gene in the genome15. 
The major identified targets of T6SS toxins to date are components of the cell wall, as well 
as the cell membrane and nucleic acids16. These T6SS toxins have mainly been identified by 
searching in the genomic proximity of known T6SS components, or by detection of toxins in 
the secretome11,14,17.
Pseudomonas aeruginosa is a highly antibiotic-resistant Gram-negative pathogen and ranked 
second by the World Health Organization in the list of bacteria that require immediate 
attention. It is also equipped with three independent T6SS systems (H1- to H3-T6SS)18. In 
the current study we used a global genomics-based approach called TraDIS (Transposon 
directed insertion-site sequencing) to identify toxins associated with the P. aeruginosa 
H1-T6SS 19. A previous study has used Tn-Seq, a similar global transposon mutagenesis 
approach, and confirmed the presence of three T6SS toxin-immunity genes which are 
located in the vicinity of vgrG genes in V. cholerae 41. Our TraDIS approach identified 
several remote and previously unidentified putative T6SS toxin-immunity pairs. We found 
that one of the identified toxins, Tse8 (Type six exported 8), targets the bacterial 
transamidosome complex, which is required for protein synthesis in bacteria that lack the 
asparagine and/or glutamine tRNA synthases20. This is a previously unidentified target for a 
T6SS toxin, demonstrating that T6SS toxins can impair bacterial protein synthesis.
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TraDIS identifies known and previously unidentified H1-T6SS toxin­
immunity pairs
To systematically identify P. aeruginosa PAK H1-T6SS associated immunity genes we 
generated duplicate high-density insertion transposon mutant libraries consisting of ~2 
million mutants in a H1-T6SS active (PAKΔretS) and a H1-T6SS inactive (PAKΔretSΔH1) 
background. We reasoned that transposon insertions in immunity genes would only be 
tolerated in the H1-T6SS inactive library, while in the H1-T6SS active library, cells lacking 
an immunity protein would be killed upon injection of the cognate toxin from neighbouring 
sister cells or due to self-intoxication. Each duplicate library was plated separately at high­
contact density on agar plates and passaged in an overnight incubation step to promote 
T6SS-mediated killing of mutants with transposon insertions in immunity genes (Extended 
data Fig. 1). The genomic DNA of mutants which were not killed in both the H1-T6SS 
active and inactive libraries were then separately sequenced using a mass-parallel approach 
as described previously21,22 (Extended Data Fig. 1). The relative frequencies of transposon 
insertion in genes in the H1-T6SS active and inactive libraries revealed a large number 
of genes which had changes in relative numbers of transposon insertions. Forty-five genes 
which had a significantly greater number of normalized transposon insertions in the H1­
T6SS inactive library background, compared to the H1-T6SS active library background, 
were identified (Supplementary Table 1), and considered as potential H1-T6SS immunity 
proteins. Our approach is validated by our ability to identify five (tsi1-tsi5) out of the seven 
known H1-T6SS immunity genes, whose gene products protect against cognate toxins acting 
in both the cytoplasm and periplasm (Table 1). Our screen was unable to identify tsi6 as this 
gene is deleted in our PAKΔretSΔH1 strain, thus there is no possibility to assess the relative 
frequency of transposon insertions in this gene between the two library backgrounds. In the 
case of tsi7 we did not see any difference in the levels of insertions between the two libraries 
(Supplementary Table 1). It is not clear why this was the case, but we cannot exclude 
the possibility that one of the uncharacterized proteins encoded by the vgrG1b cluster23 
containing the tse7-tsi7 pair, or a gene elsewhere in the genome, can also confer protection 
against the Tse7 toxin in the absence of Tsi7.
In addition to known H1-T6SS associated immunity genes, our TraDIS approach identified 
multiple uncharacterised small coding sequences that displayed a decrease in transposon 
insertions in the H1-T6SS active, compared to the inactive, background (represented 
by a negative log fold change), suggesting a role for these genes in protecting against 
H1-T6SS mediated killing (Supplementary Table 1). Upstream of several of these loci 
were genes encoding proteins with putative enzymatic activity which could be T6SS 
toxins: PAKAF_04415 (PA0801) encodes a putative M4 peptidase regulator; PAKAF_02303 
(PA2778) encodes a putative C39 peptidase domain-containing protein; PAKAF_01709 
(PA3272) encodes a putative nucleoside triphosphate hydrolase; and PAKAF_00798 
(PA4163) encodes a putative amidase (Table 1 and Extended Data Fig. 2). In the 
present study, we selected the putative toxin/immunity pair PAKAF_00798/PAKAF_00797 
(PA4163/PA4164) for further characterization, and we refer to it as tse8-tsi8 (type six 
exported 8-type six immunity 8) in all subsequent sections.
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Tse8-Tsi8 is a toxin-immunity pair
To assess the toxic role of Tse8, a strain lacking both tse8 and the downstream putative 
immunity gene (tsi8) was generated in a PAKΔretS background, yielding PAKΔretSΔtsei8. 
In this mutant, expression of tse8 from pMMB67HE with and without a C-terminal HA tag 
affected growth (Fig. 1a). Furthermore, in a competition assay this mutant strain carrying a 
lacZ reporter gene (recipient PAKΔretSΔtsei8::lacZ) was outcompeted only by donor strains 
with an active H1-T6SS, i.e. PAKΔretS or PAKΔretSΔH2ΔH3 (Fig. 1b). The observed 
killing of the receiver strain was further demonstrated to be Tse8-dependent in competition 
assays with a donor lacking Tse8 (Extended Data Fig. 3a). The PAKΔretS strain lacking 
either tsei8 or tse8 could be complemented in a competition assay by expression of tsei8 
from pBBR-MCS5 or tse8 from pBBR-MCS4 (Extended Data Fig. 3b, c).
The toxicity associated with the H1-T6SS-dependent delivery of Tse8 into a sensitive 
receiver strain could be rescued by expressing the tsi8 immunity gene from pJN105 in both 
a competition assay (Fig. 1c) and a growth assay (Fig. 1d), further confirming the protective 
role of Tsi8. In several cases, T6SS immunity proteins have been shown to directly interact 
with their cognate toxins17,24,25. Here, bacterial-two-hybrid (BTH) assays demonstrate that 
indeed Tse8 interacts strongly with Tsi8 (Fig. 1e). In addition, pull-down experiments using 
Tsi8-His as a bait, show direct interaction of the two proteins (Fig. 1f); this interaction is 
specific to Tsi8 as almost no Tse8-HA-Strep elutes from the pull-down beads in the absence 
of Tsi8 or in the presence of the non-specific binding control, CcmE-His (Fig. 1f).
T6SS toxin delivery frequently relies on a direct interaction between the toxin and 
components of the T6SS spike11,14. BTH assays (Fig. 2a), as well as dot blot assays, 
revealed that Tse8 interacts strongly with VgrG1a (Fig. 2b). While the interaction of 
Tse8 with VgrG1c was significant in the BTH assay (Fig. 2a), no interaction above the 
non-specific binding control (CcmE-His) was observed in the dot blot assay (Fig. 2b). 
Finally, no interaction between Tse8 and VgrG1b was observed in BTH (Fig. 2a) or dot blot 
assays (Fig. 2b).
Overall, the above results demonstrate that Tse8-Tsi8 is an antibacterial toxin-immunity 
pair associated with the H1-T6SS, and that Tse8 interacts with the VgrG1a tip to facilitate 
delivery into target cells.
Tse8 is a predicted amidase family enzyme
Using Phyre226 we found that the closest 3D homologs of Tse8 are the Stenotrophomonas 
maltophilia Peptide amidase (Pam)27 (sequence identity 29%), the Staphylococcus aureus 
Gln-tRNA(Gln) transamidosome subunit A (GatA)28 (sequence identity 20%), the P. 
aeruginosa Asn-tRNA(Asn) transamidosome subunit A (GatA)29 (sequence identity 25%), 
the Flavobacterium sp. 6-aminohexanoate cyclic dimer hydrolase (NylA)30 (sequence 
identity 24%), the Bradyrhizobium japonicum malonamidase E2 (MAE2)31 (sequence 
identity 25%), the Pseudomonas sp. allophanate hydrolase (AtzF)32 (sequence identity 
30%), and the Bacterium csbl00001 Aryl Acylamidase (AAA)33 (sequence identity 22%). 
Amino acid sequence analysis indicates that Tse8 contains an Amidase Signature (AS) 
Nolan et al. Page 4













domain (Pfam PF01425) (Extended Data Fig. 4). AS sequences are characterized by a 
stretch rich in glycine and serine residues, as well as a highly conserved Ser-cisSer-Lys 
catalytic triad27,28,34–37. The catalytic Lys is located in the C-terminal end of a conserved 
β-strand (region 1) (Extended Data Fig. 4), while the cisSer is located at the C-terminus 
of region 2 (Extended Data Fig. 4). Finally, the nucleophilic Ser residue is located in a 
highly conserved short loop of region 3. All these AS signature sequence characteristics 
(underlined by a dashed line in Extended Data Fig. 4) are present in Tse8 and its closest 3D 
homologues.
Given that Tse8 possesses the conserved catalytic features of amidase family enzymes 
(Extended Data Fig. 4), we tested whether it has amidase activity. Tse8 was purified and 
confirmed to be intact (Extended Data Fig. 5). Subsequently, its capacity to hydrolyse 
carbon-nitrogen bonds was tested on two molecules, epinecidin-1 and glutamine, which 
are substrates for Pam from S. maltophilia and GatA of the transamidosome, respectively. 
The amidase activities of Pam and Tse8 were analysed by Mass Spectrometry (MS) by 
monitoring the modifications of epinecidin-1 in the presence and absence of the tested 
proteins and of the small nucleophile hydroxylamine (Extended Data Fig. 6). While the 
C-terminus of epinecidin-1 was deaminidated in the presence of Pam (Extended Data Fig. 
6b), it remained amidated in the presence of Tse8, suggesting that Tse8 has no amidase 
activity on this substrate (Extended Data Fig. 6 and Extended Data Fig. 7). The amidase 
activity of Tse8 was also tested on the GatA substrate glutamine (Extended Data Fig. 8) 
and no modification was detected by MS (Extended Data Fig. 8b). In addition, whole-cell 
glutaminase assays were performed and the amidase activity of E. coli whole cell lysates 
expressing GatA or Tse8 on L-glutamine was determined by monitoring the accumulation 
of NADPH. These experiments demonstrated that while GatA expressed from plasmid 
pET41a had a significant amidase activity, whole cells expressing Tse8 from the same 
vector produced a level of NADPH which was not significantly different to the empty 
vector-carrying control strain (Extended Data Fig. 8c). Overall, these data demonstrate that 
the substrates for Pam and GatA are not substrates for Tse8, suggesting that Tse8 is highly 
specific or unlikely to utilize amidase activity to elicit toxicity.
To assess whether Tse8 toxicity is mediated through amidase activity in vivo, we replaced 
the tse8 gene on the chromosome by an allele encoding a putative catalytic site mutant 
of Tse8 with a Ser186Ala (S186A) substitution. This conserved Ser186 residue (Extended 
Data Fig. 4) acts as the catalytic nucleophile in homologous amidases, and is necessary for 
enzymatic function38. PAKΔretS and PAKΔretSΔH1 donor strains encoding either wild-type 
Tse8 or Tse8S186A were competed against the recipient strain PAKΔretSΔtsei8::lacZ. This 
showed that there was no difference in the recovered CFUs/mL of the recipient when the 
attacking strain delivered either wild-type Tse8 or Tse8S186A (Fig. 2c), further suggesting 
that Tse8 does not utilize amidase activity to elicit toxicity in vivo.
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Tse8 elicits toxicity by interacting with the bacterial amidotransferase 
complex
Since Tse8 toxicity does not appear to depend on it having amidase activity (Fig. 2c), we 
hypothesized that Tse8 could instead be eliciting toxicity by competing with a functional 
amidase either within the cell, or within a complex in the cell. Two 3D homologues 
of Tse8 are the A subunit of the S. aureus Gln-tRNA(Gln) transamidosome and the P. 
aeruginosa Asn-tRNA(Asn) transamidosome. Both of these proteins are the A subunit 
of transamidosome complexes, which are used by bacteria that lack the cognate tRNA 
synthases for asparagine (Asn) and/or glutamine (Gln)20. These bacteria utilize a two-step 
pathway instead, whereby a non-discriminating tRNA synthase generates a misacetylated 
aspartate- or glutamate-loaded tRNA which is then transaminated by the heterotrimeric 
amidotransferase enzyme GatCAB, within the transamidosome complex, to leave asparagine 
or glutamine correctly loaded onto their cognate tRNA. Given that not all bacteria rely on 
the transamidosome for protein synthesis, we reasoned that if Tse8 toxicity is directed at this 
enzymatic complex, then expression of Tse8 should only be toxic in bacteria which use the 
transamidosome. P. aeruginosa relies on the transamidosome for Asn-tRNA synthesis39 and 
we see a growth defect when Tse8 is expressed from a plasmid or delivered into a strain 
lacking Tsi8 (Fig. 1a-d). Agrobacterium tumefaciens lacks both Asn-tRNA and Gln-tRNA 
synthases and generates these cognate tRNAs through the transamidosome (Supplementary 
Table 4), while E. coli possesses both the Asn- and Gln-tRNA synthases and does not 
have a transamidosome complex (Supplementary Table 4). The effect of Tse8 expression 
was examined for both A. tumefaciens and E. coli. A growth defect was observed for A. 
tumefaciens, which could be rescued by co-expression of Tsi8 (Fig. 3a), but no growth 
defect was observed for E. coli (Fig. 3b) despite Tse8 expression at high levels from pET28a 
(Fig. 3c). Taken together these data suggest that Tse8 toxicity depends on the presence of the 
transamidosome.
We generated a structural homology model of Tse8 based on the solved S. aureus GatA 3D 
structure (PDB: 2F2A). By overlaying this model with the A subunit of the P. aeruginosa 
transamidosome structure (PDB: 4WJ3) (Extended Data Fig. 9a), we found that Tse8 shares 
a high level of structural similarity to the A subunit of the complex. Further, comparison 
of the homologous residues within the substrate binding pockets of SaGatA and PaTse8 
revealed that while the catalytic triad residues are conserved, the substrate binding residues 
(Tyr309, Arg358 and Asp425 in SaGatA)24 are not (Extended Data Fig. 9b), supporting our 
data and hypothesis that Tse8 does not have the same substrate as GatA (Extended Data 
Fig. 8). While this manuscript was in preparation a structure for Tse8 was published (RDB: 
6TE4)40 that agrees with the overall conclusions from our homology modelling data.
Given the high level of predicted structural similarity between GatA and Tse8 we 
hypothesized that Tse8 may be able to interact with the transamidosome and could be 
eliciting toxicity by altering the functionality of this complex. The most likely scenario 
was that Tse8 replaces GatA, thus rendering the GatCAB complex inactive. To investigate 
this, we performed a pull-down experiment using purified proteins. GatCAB was purified 
as a complex using a Ni-affinity column through histidine-tagged GatB (His-GatB); GatA 
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and GatC also had tags which were appropriate for their detection by western blot (GatA­
V5 and GatC-HA). Tse8 was purified separately through a StrepII tag (Tse8-HA-Strep). 
GatCAB was pulled down in the presence and absence of a 15-fold molar excess of Tse8 
via His-GatB on His-Tag Dynabeads. Tse8 was found to co-purify with GatCAB (lane 
2, Fig. 3d). This interaction is specific to GatCAB, as minimal amounts of Tse8 elute 
from the pull-down beads in the absence of the transamidosome or in the presence of the 
non-specific binding control (CcmE-His) (Fig. 3d). However, even though a large molar 
excess of Tse8 was used in our pull-down experiment, the amount of GatA detected in the 
GatCAB complex remained largely unaffected (lane 2, Fig. 3d) excluding the possibility that 
Tse8 displaces GatA.
Another possibility was that Tse8 interacts with transamidosome components as the 
GatCAB complex assembles and that this interaction disrupts transamidosome function. 
To test this hypothesis, we purified GatBC as a complex using a Ni-affinity column through 
histidine-tagged GatB (His-GatB) and used this complex in pull-down experiments with 
cell lysates containing GatA and Tse8; GatA, GatC and Tse8 also had tags which were 
appropriate for their detection by western blot (GatA-V5, GatC-HA and Tse8-HA-Strep). 
We found that that the presence of Tse8, rather than inhibiting the binding of GatA to 
GatBC as we initially hypothesized, promotes it (lane 2, Fig. 3e), leading to a drastic 
accumulation of GatA on the GatBC complex (Fig. 3f). This GatA accumulation is specific 
to the presence of Tse8 and GatBC, as no GatA elutes from the pull-down beads in the 
absence of these proteins or in the presence of the non-specific binding control (CcmE­
His) (Fig. 3e). The fact that we did not observe GatA accumulation upon Tse8 exposure 
in our pull down using intact GatCAB (Fig. 3d), suggests that Tse8 is more effective 
when it is acts on transamidosome components during the assembly of this complex. 
The structure of the P. aeruginosa GatCAB transamidosome reveals it to be a symmetric 
complex comprising an aspartyl-tRNA synthase (ND-AspRS), GatCAB, and tRNAAsn in 
a defined 2:2:2 stoichiometry29 (as represented in Extended Data Fig. 9aa). The function 
of this complex relies on large conformational changes between the ND-AspRS and the 
GatCAB components that are fine-tuned to accommodate the movement of the tRNAAsn 
between the domains of the transamidosome super-complex29. As such, additional Tse8 
and GatA domains attached to the optimal transamidosome complex structure would likely 
inhibit transamidosome function by obstructing the communication between the ND-AspRS, 
GatCAB and the tRNAAsn. This in turn would result in a decrease in the production of 
Asn-tRNAAsn, ultimately impairing protein synthesis.
To further support our data suggesting that Tse8 exerts its toxicity by impairing protein 
synthesis through inhibition of the transamidosome, we hypothesized that if we were able 
to override the need for transamidosome function by providing the bacterium with the 
tRNA synthase it lacked, we would be able to rescue the observed growth defect when 
Tse8 is either expressed from a plasmid (Fig. 1a,d) or delivered by an attacker (Fig. 
1b,c). P. aeruginosa only lacks the asparagine tRNA synthase39 (Supplementary Table 
4), thus in this case Tse8 toxicity should be rescued by simply providing the cell with 
this tRNA synthase. To investigate this possibility, the Asn-tRNA synthase (asnS) from 
E. coli was expressed in PAKΔretSΔtsei8 from pJN105, and the strain competed against 
PAKΔretS and PAKΔretSΔH1. Expression of AsnS was able to rescue Tse8 toxicity (Fig. 
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4a) to the same extent as expression of the cognate immunity protein, Tsi8 (Fig. 1c). 
Furthermore, to directly test the effect of Tse8 expression on protein synthesis in vivo we 
expressed superfolder Gfp (sfGfp) from the Tn7 site of the P. aeruginosa chromosome in 
a Tse8-sensitive strain (PAKΔretSΔtsei8) that also expressed Tse8 or harboured the empty 
pMMB67HE vector. We found that the strain expressing Tse8 produces less sfGfp compared 
to the empty vector control (sfGfp signal was normalised to OD600; Fig. 4b), while this 
effect is specific to Tse8, since the decrease in sfGfp/total cells level in the presence of Tse8 
could be rescued by co-expression of Tsi8 (Fig. 4b). Finally, co-expression of Tse8 with E. 
coli AsnS, also rescues the production of sfGfp/total cells (Fig. 4b), demonstrating that the 
decrease in fluorescent signal observed in the presence of Tse8 alone is originating from 
the specific interaction of Tse8 with its target, the transamidosome complex. Together these 
data demonstrate that strains containing Tse8 are less able to produce sfGfp, which, in turn, 
indicates that protein synthesis is inhibited by this T6SS toxin.
Discussion
In the current study we demonstrate that our global genomic approach can be used to 
identify T6SS toxin-immunity pairs associated with the H1-T6SS of P. aeruginosa. Our 
approach not only confirmed previously characterized P. aeruginosa T6SS toxin-immunity 
pairs, but also revealed several previously unidentified putative toxin-immunity pairs, 
including Tse8-Tsi8, which would probably not have been found using targeted approaches 
or bioinformatics. Characterization of the Tse8-Tsi8 pair, revealed that Tsi8 is the cognate 
immunity protein for the Tse8 toxin, and that Tse8 interacts with VgrG1a, hence it is likely 
delivered into target cells via the VgrG1a-tip complex.
Tse8 was also found to interact with GatCAB of the bacterial transamidosome complex, 
which is required for protein synthesis in certain bacteria that lack one or both of the 
asparagine or glutamine tRNA synthases20. Our pull-down data (Fig. 3e,f) demonstrate 
that Tse8 interaction with transamidosome components leads to accumulation of GatA 
onto GatBC, resulting in an amidotransferase complex with altered stoichiometry. 
Transamidosome function depends on a series of interactions between its ND-AspRS, 
GatCAB and the tRNAAsn components. These interactions are, in turn, reliant on the 
optimal architecture of the transamidosome that allows for extensive conformational changes 
to take place in order for the tRNAAsn to efficiently move between the domains of the 
super-complex29. It would be expected that Tse8-mediated precipitation of several additional 
GatA molecules on this complex will impact upon its fine-tuned architecture, resulting in 
functional deficits. According to our pull-down data, very little Tse8 is pulled with GatBC 
(Fig. 3e; all the blots in this figure have been exposed for the same amount of time using 
comparable commercial antibodies). This small amount of toxin is sufficient to nucleate 
the accumulation of GatA in significant amounts (Fig. 3f) and impair transamidosome 
function. Overall, this is in agreement with the logistics of Tse8 being delivered through the 
VgrG1a-tip complex, since only a maximum of three molecules of toxin can be delivered per 
T6SS firing event through VgrG. Based on this data, we propose that in bacteria where the 
transamidosome is essential (i.e. in bacteria lacking one or both of the Asn- or Gln-tRNA 
synthases), activity of Tse8 results in reduced fitness due to decreased levels of protein 
synthesis. In agreement with this, Tse8 toxicity can be rescued if the transamidosome 
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function is bypassed upon provision of the transamidosome-independent tRNA-synthase 
lacked by the bacterium (i.e. AsnS for P. aeruginosa (Fig. 4a and 4b)).
Future work, focusing on further characterization of the specifics of the Tse8-GatCAB 
interaction, could point to ways of inhibiting the transamidosome and may provide a basis 
for the development of antibacterial agents against this target. Such agents might be useful 
in inhibiting the growth of important pathogens that rely on the transamidosome, without 
affecting the viability of many commensal bacteria which produce their proteins without 
depending on this pathway. Moreover, investigation of the other putative toxins detected in 
this study could also open new therapeutic avenues; elucidation of the substrates of these 
putative toxins could offer insights into pathways that are naturally validated antibacterial 
targets against P. aeruginosa. Looking beyond the T6SS of P. aeruginosa, there are many 
Gram-negative bacteria that infect human and animal hosts, or are plant pathogens or 
plant-associated organisms and possess at least one, if not multiple T6SSs clusters41–44. 
Furthermore, in several cases it has been demonstrated that distinct T6SS machines deliver 
a specific subset of toxins into target cells, often under certain conditions9,12,16, suggesting 
that toxins are not only bacterial specific, but potentially even niche specific. Given this 
diversity, we predict that our TraDIS approach could be useful for drastically expanding the 
repertoire of known T6SS toxins across a range of bacteria and ecologically or clinically 
relevant growth environments.
Methods
Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are reported in Supplementary Table 2. P. 
aeruginosa PAK was used for TraDIS library generation and subsequent assays using mutant 
strains generated by allelic exchange mutagenesis as described previously45,46. P. aeruginosa 
strains were grown in tryptone soy broth (TSB), Lysogeny Broth (LB) or M9 or MOPS 
minimal media (with indicated supplements), supplemented with antibiotics as appropriate 
(streptomycin 2000 μg/mL, carbenicillin 100 μg/mL, gentamicin 50 μg/mL) at 37 °C with 
agitation. E. coli strains DH5α, SM10, CC118λpir and BL21(DE3) were used for cloning, 
conjugation and protein expression steps. E. coli cells were grown in TSB, LB, Terrific 
Broth or M9 minimal media (with indicated supplements), supplemented with antibiotics 
as appropriate (streptomycin 50 μg/mL, ampicillin 100 μg/mL, kanamycin 50 μg/mL) at 
37 °C with agitation. A. tumefaciens C58 was grown in LB or M9 minimal media (with 
indicated supplements), supplemented with antibiotics as appropriate (gentamicin 50 μg/mL, 
spectinomycin 100 μg/mL) at 30 °C with agitation.
DNA manipulation
DNA isolation was performed using the PureLink Genomic DNA mini kit (Life 
Technologies) except for TraDIS library genomic DNA isolation (see below). Isolation 
of plasmid DNA was carried out using the QIAprep spin miniprep kit (Qiagen). Primers 
(Sigma) used are shown in Supplementary Table 3. DNA fragments were amplified with 
either KOD Hot Start DNA Polymerase (Novagen) or standard Taq polymerase (NEB) as 
described by the manufacturer, with the inclusion of Betaine (Sigma) or DMSO (Sigma). 
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Restriction endonucleases (Roche) were used according to the manufacturer’s specifications. 
DNA sequencing was performed by GATC Biotech.
TraDIS library generation
A highly saturated transposon mutant library was generated in P. aeruginosa PAKΔretS 
or PAKΔretSΔH1 strains by large scale conjugation with an E. coli SM10 [pBT20] donor 
which allowed for random insertion of a mariner transposon throughout the genome and 
conferred gentamicin resistance in the recipient PAK strain. The E. coli donor strain was 
grown in LB supplemented with gentamicin (15 μg/mL) overnight at 37 °C and the recipient 
PAK strain was grown overnight at 37 °C in LB. Equivalent amounts of both strains were 
spread uniformly on separate LB agar plates and incubated overnight at 37 °C for E. coli and 
at 43 °C under humid conditions for the PAK recipient. The next day one E. coli donor plate 
was harvested and combined by extensive physical mixing on a fresh LB agar plate with one 
plate of harvested recipient PAK strain. Conjugation between the two strains was achieved 
by incubation of the high-density mixture of both strains at 37 °C for 2 hrs under humid 
conditions. The conjugation mix was then harvested, pelleted by centrifugation (10,000 g, 10 
mins, 4 °C), and resuspended in LB. The resuspended cells were recovered onto large square 
(225 mm) Vogel-Bonner Media (VBM) (MgSO4.7H2O (8 mM), citric acid (anhydrous) (9.6 
mM), K2HPO4 (1.7 mM), NaNH5PO4.4H20 (22.7 mM), pH 7) agar plates supplemented 
with gentamicin (60 μg/mL) and incubated for 16 hrs at 37 °C. The numbers of mutants 
obtained were estimated by counting a representative number of colonies across multiple 
plates. Mutants for each library background on plates were recovered as two separate pools 
(T6SS active and T6SS inactive), resuspended in LB, then pelleted by centrifugation (10,000 
g, 10 mins, 4 °C), and then finally resuspended in LB plus glycerol (15% (v/v)) and stored 
at -80 °C. The protocol was repeated on a large scale until ~2 million mutants were obtained 
in each library background. For the TraDIS assay glycerol stocks of harvested PAKΔretS or 
PAKΔretSΔH1 TraDIS libraries were combined at normalized cell density for each separate 
replicate (i.e two final pools in total) and spread onto large square (225 mm) VBM agar 
plates supplemented with gentamicin (60 μg/mL) and incubated for 16 hrs at 37 °C to 
facilitate T6SS delivery of toxins and subsequent killing/self-intoxication of mutants lacking 
immunity genes for the cognate toxin. Cells were then harvested into 5 mL LB and pelleted 
by centrifugation (10,000 g, 15 mins, 4 °C). Cell pellets were resuspended in 1.4 mL LB and 
1 mL was retained for subsequent genomic DNA extraction (see ‘TraDIS library genomic 
DNA extractions’ section below).
TraDIS library assay
Glycerol stocks of harvested PAKΔretS or PAKΔretSΔH1 TraDIS libraries were combined at 
normalized cell density for each separate replicate and spread onto large square (225 mm) 
VBM agar plates supplemented with gentamicin (60 μg/mL) and incubated for 16 h at 37 
°C. Cells were then harvested into 5 mL LB and pelleted by centrifugation (10,000 g, 15 
min, 4 °C). Cell pellets were resuspended in 1.4 mL LB and 1 mL was taken for subsequent 
genomic DNA extraction (see below).
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TraDIS library genomic DNA extractions
Genomic DNA from the harvested pooled library pellets either before or after undergoing 
the ‘TraDIS library assay’ (above) were resuspended in 1.2 mL lysis solution (10 mM 
Tris-HCl, 400 mM NaCl and 2 mM Na2EDTA, supplemented with Proteinase K in storage 
buffer (50 mM Tris-HCl, 50% (v/v) glycerol, 100 mM NaCl, 0.1 mM EDTA, 10mM CaCl2, 
0.1% (v/v) Triton X-100 and 1 mM DTT) to a concentration of 166 μg/mL. Cell lysis was 
achieved by incubation at 65 °C for 1 h, with occasional vortexing. The samples were then 
cooled to room temperature and RNA removed by addition of RNase A (5 μg/mL) and 
incubation at 37 °C for 80 min. Samples were then placed on ice for 5 min. Each lysate 
was then split into 2 eppendorf tubes at ~600 μL per tube, and 500 μL NaCl (5 M) were 
added to each tube. Cell debris were removed by centrifugation (10,000 g, 10 min, 4 °C) 
and 500 μL from each tube was added to 2 volumes of isopropanol to precipitate the DNA. 
DNA was then collected by centrifugation (10,000 g, 10 min, 4 °C), and DNA pellets were 
washed twice in 70% (v/v) ethanol. The fully dried DNA pellet was finally resuspended in 
Tris-EDTA buffer.
PAK reference genome
The PAK genome under the NCBI number accession number LR657304, also listed in the 
European Nucleotide Archive (ENA) under accession number ERS195106, was used. See 
details in Cain et. al. (2019)47. PAK loci in Table 1, Extended Data Fig. 9 and throughout the 
text are the corresponding loci names from this genome.
Generation of TraDIS sequencing libraries, sequencing and downstream analysis
TraDIS sequencing was performed using the method described previously22, with some 
minor modifications for this study, as described below. Also see Extended Data Fig. 10, and 
Supplementary Table 1.
PCR primers were designed for library construction and used for both the PAK libraries 
(5′: AATGATACGGCGACCACCGAGATCTACACACAGGAAACAGGACTCTAGAGG 
ATCACC and 3′: AATGATACGGCGACCACCGAGATCTACACCTTCTGTATGGAACG 
GGATGCG) and the sequencing TraDIS primers (5′: CAGCTTTCTTGTACACTAGA 
GACCGGGGACTTATCAG, and 3′: AAGCCTGCTTTCTAGAGACCGGGGACTTAT 
CAG). During library production, a post-ligation double digest with restriction enzymes 
AgeI and SgrAI was performed according to the manufacturer’s instructions (New England 
Biolabs) to prevent amplification of plasmid background. The T6SS TraDIS sequencing was 
performed on a HiSeq2500 Illumina platform on the RAPID 50bp SE read setting. Reads 
were mapped onto the PAK genome (accession number: ERS195106), and comparisons 
were performed using the TraDIS Toolkit informatics package22. 10% of the 3′ end of each 
gene was discounted, and a 10 read minimum cut-off was used to be included in analysis. 
On average there was a unique transposon insertion site every 53 bp over the whole genome 
for each of the T6SS active and T6SS inactive backgrounds and, thus the genome was 
highly saturated in each library. The distribution of transposon insertions across the genome 
based upon the normalized transposon insertions in a H1-T6SS inactive library background, 
compared to the H1-T6SS active library background is shown in Extended Fig. 10. The 
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resulting sequences of the T6SS TraDIS assays are available from the European Nucleotide 
archive (ENA) under study accession number PRJEB1597.
To pinpoint genes involved in protection of T6SS-mediated killing, EdgeR48 was used to 
identify significant differences in read counts of genes in strains with (PAKΔretS) and 
without (PAKΔretSΔH1) an active H1-T6SS. Then the trimmed mean of M values (TMM) 
normalization was used to account for differences between then libraries, and tagwise 
dispersion was estimated. Only genes exhibiting greater than 5 reads in both replicates of 
the conditions or control sets were examined for differences in the prevalence of mutants. 
Genes with zero read counts in the other condition were offset using the prior count function 
in EdgeR48 so that fold changes could be estimated. P values were corrected for multiple 
testing using the Benjamini-Hochberg method, and genes with a corrected P value (Q 
value) of <0.05 (5% false discovery rate) and an absolute log2 fold change (log2FC) 
of >2 were considered significant (see Tab 2 in Supplementary Table 1). A list of 49 
genes resulted having statistically significant decreased insertions in the T6SS active library 
PAKΔretS compared to normalized values in the PAKΔretSΔHI library. These genes were 
then interrogated as potential immunities, based firstly on gene size (the known H1-T6SS 
associated immunity genes (tsi1-6) at the time of analysis are all less than 600bp, thus this 
was used as a guide to shorten the list to 29 genes) (see Tab 3 in Supplementary Table 1) and 
also on whether a protein upstream these genes appeared to have a predicted enzymatic or 
putative toxin function.
Bacterial growth assays
Growth assays were performed as follows. For Fig. 1a, overnight cultures of 
PAKΔretSΔtsei8 were diluted down to OD600 = 0.1 in M9 minimal media (supplemented 
with MgSO4 (2 mM), CaCl2 (0.1 mM), glucose (0.4% (w/v)) and FeSO4.7H2O (0.01 mM)) 
and grown shaking at 37 °C. Expression of Tse8 was induced with IPTG (1 mM) at 4 
h. For Fig 1d, PAKΔretSΔtsei8 cells carrying both pJN105 and pMMB67HE plasmids 
(+/- Tsi8/Tse8) were grown in MOPS minimal media (MOPS (40mM, pH 7.5), Tricine 
(4 mM, pH 7.5), NH4CL (9.52 mM), CaCL2 (0.5 uM), MgCl2.7H20 (0.52 mM), NaCl 
(50 mM), FeSO4.7H2O 20 mM (0.01 mM), K2HPO4 (1.32 mM) supplemented with 1x 
micronutrient mix (100x: Ammonium molybdate tetrahydrate (3 uM), Boric acid (400 uM), 
Cobalt chloride (30 uM), Cupric sulphate (10 uM), Manganese chloride (80 uM), Zinc 
sulphate (10 uM) and Nickel chloride hexahydrate (0.1% (w/v/)) and glucose (0.4% (w/v)) 
and L-Glutamine (0.05% (w/v)) shaking at 37 °C (without antibiotics). Expression of Tse8 
was induced with IPTG (1 mM) and Tsi8 with arabinose (0.2% (w/v)) at 5 h. For Fig. 
3a, overnight cultures of A. tumefaciens with pTrc200/pJN105 plasmids (+/- Tse8/Tsi8) 
were diluted down to OD600 = 0.1 in MOPS media without antibiotics as above and grown 
shaking at 30 °C. Expression of Tse8 was induced with IPTG (1 mM) and Tsi8 with 
arabinose (0.2% (w/v)) at 8 h. For Fig. 3b, overnight cultures of E. coli were diluted down 
to OD600 = 0.1 in M9 minimal media (supplemented with MgSO4 (2 mM), CaCl2 (0.1 
mM), FeSO4.7H2O (0.01 mM) and glucose (0.4% (w/v)) and grown shaking at 37 °C. Tse8 
expression was induced with IPTG (1 mM) after 2 h. For Fig. 4b, overnight cultures of the 
indicated P. aeruginosa strain were diluted down to OD600 = 0.1 in LB (without antibiotics) 
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and grown shaking at 37 °C. Expression of Tse8 was induced with IPTG (0.25 mM) and 
Tsi8 or AsnS with arabinose (0.2% (w/v)) at 0 h.
T6SS competition assays
T6SS competition assays were performed as described previously49 with modifications as 
indicated. Briefly, overnight cultures of donor and recipient bacteria alone or in a 1:1 
ratio were combined and spot plated on LB agar plates for 5 h at 37 °C and recovered 
in serial dilution on LB agar plates supplemented with Xgal (5-bromo-4-chloro-3-indolyl-β­
D-galactopyranoside) (100 μg/mL) to differentiate recipient (PAKΔretSΔtsei8::lacZ seen as 
blue) from donor (white). For recovery of competition assays between donor and recipient 
PAKΔretSΔtsei8 [pBBR1-MCS5] and [pBBR1:tsei8], the competition assay was plated 
onto LB agar plates with gentamicin (50 μg/mL) to differentiate donor from recipient 
(GmR). For recovery of competition assays between donor and recipient PAKΔretSΔtsei8 
[pBBR1-MCS4] and [pBBR4:tse8], the competition assay was plated onto LB agar plates 
with carbenicillin (50 μg/mL) to differentiate donor from recipient (CarbR). In other cases, 
expression of Tsi8 or AsnS in the recipient strains was induced in the overnight cultures by 
addition of arabinose (0.2% (w/v)). These overnight cultures of donor and induced recipient 
alone or in a 1:1 ratio, were combined and spot plated onto LB agar supplemented with 
arabinose (1% (w/v)) for induction of Tsi8-V5 or AsnS-His for 5 h, with the competition 
assay finally being recovered on LB agar plates supplemented with gentamycin (50 μg/mL) 
and arabinose (1% (w/v)).
Bacterial Two Hydrid (BTH) and β-Galactosidase assays
Protein-protein interactions were analysed using the BTH system as described previously50. 
Briefly, the DNA region encoding the protein of interest were amplified by PCR and were 
then cloned into plasmids pKT25 and pUT18C, which each encode for complementary 
fragments of the adenylate cyclase enzyme, as previously described50 resulting in N­
terminal fusions of T25/T18 from the adenylate cyclase to the protein of interest. 
Recombinant pKT25 and pUT18c plasmids were simultaneously used to transform the 
E. coli DHM1 strain, which lacks adenylate cyclase, and transformants were spotted onto 
Xgal (40 μ/mL) LB agar plates supplemented with IPTG (1 mM), Km (50 μg/mL) and 
Amp (100 μg/mL). Positive interactants were identified after incubation at 30 °C for 48 h. 
The positive controls used in the study were pUT18C or pKT25 derivatives encoding the 
leucine zipper from GCN4, which forms a dimer under the assay conditions. The strength 
of the interactions in the BTH assays was quantified from the β-galactosidase activity of 
co-transformants scraped from Xgal plates and measured as described previously; activity 
was calculated in Miller units50.
Western Blot analysis
SDS-PAGE and western blotting were performed as described previously11. Proteins were 
resolved in 8%, 10%, 12% or 15% gels using the Mini-PROTEAN system (Bio-Rad) and 
transferred to nitrocellulose membrane (GE Healthcare) by electrophoresis. Membranes 
were blocked in 5% (w/v) milk (Sigma) before incubation with primary antibodies (anti-His 
at 1:1000 dilution and anti-V5 or anti-HA at 1:5000 dilution). Membranes were washed with 
TBST (0.14 M NaCl, 0.03 M KCl and 0.01 M phosphate buffer plus Tween 20 (0.05% v/v)) 
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before incubation with HRP-conjugated secondary antibodies (Sigma; anti-mouse at 1:5000 
dilution). The resolved proteins on the membrane blots were detected using the Novex ECL 
HRP Chemiluminescent substrate (Invitrogen) or the Luminata Forte Western HRP substrate 
(Millipore) using a Las3000 Fuji Imager. For Fig. 3c, samples were taken after 8 h of 
growth and expression of Tse8 was assessed by Western blot as above; detection of Tse8 
was performed using anti-HA antibody (1:5000 dilution).
Dot blotting
For Tse8 interactions with VgrG1a, VgrG1b and VgrG1c purified untagged Tse8 was 
spotted on nitrocellulose membrane (3 mg/ml) and dried at room temperature. Membranes 
were blocked with TBST with 5% (w/v) milk or 2.5% (w/v) bovine serum albumin for 
7 h at room temperature. E. coli overexpressing VgrG1a-V5, VgrG1b-V5, VgrG1c-V5 or 
CcmE-His (equivalent 150 OD600 units) were pelleted and then resuspended in 10 mL 
100 mM NaCl, 20 mM Tris, 10% (w/v) glycerol, 2% (w/v) milk powder and 0.1% (v/v) 
Tween-20 (Tween-20 was added after sonication) (pH 7.6) and sonicated. 10 mL of the 
crude lysates were applied directly to the membranes and incubated overnight at room 
temperature. The membranes were immunoblotted with anti-V5 (1:5000 Invitrogen) or anti­
His (1:1000 Sigma) overnight at 4 °C and anti-mouse secondary (1:5000). Quantification of 
dot blots was performed using the Gel Analyzer plugin in ImageJ51. Levels were normalised 
to the control signal based on 3 independent experiments.
Pull-down experiments
E. coli BL21(DE3) strains expressing simultaneously GatA-V5, GatB-His and GatC-HA or 
GatB-His and GatC-HA were grown in LB at 37°C to an OD600 of 0.8 and expression was 
subsequently induced using 1 mM IPTG (Sigma) for 16 h at 18 °C. E. coli BL21(DE3) 
cells expressing Tse8-HA-Strep were grown in Terrific Broth at 37°C to an OD600 of 0.8 
and expression was subsequently induced using 1 mM IPTG (Sigma) for 16 h at 30 °C. 
The same expression strategy used for Tse8-HA-Strep was also used for E. coli BL21(DE3) 
strains expressing Tsi8-His or CcmE-His except that TSB medium was used. Cell pellets 
resulting during expression of GatCAB, GatBC, Tsi8 or CcmE were resuspended in 
buffer A (50 mM Tris-HCl, 150 mM NaCl, 20 mM imidazole (pH 7.5)) and lysed by 
sonication after the addition of protease inhibitors (Roche). Cell debris were eliminated by 
centrifugation (48,000 g, 30 min, 4 °C). Proteins were purified by immobilized metal affinity 
chromatography using nickel-Sepharose resin (GE Healthcare) equilibrated in buffer A. 
Proteins were then eluted off the resin with buffer A containing 200 mM instead of 20 mM 
imidazole. Cell pellets resulting during expression of Tse8 were resuspended in 50 mM Tris­
HCl, 150 mM NaCl (pH 7.5) and lysed by sonication after the addition of protease inhibitors 
(Roche). Tse8-HA-Strep was purified using Strep-Tactin Sepharose (IBA), according to the 
manufacturer’s specifications.
For pull-down experiments using pure-proteins, the above purified protein solutions and 
His-Tag Isolation & Pull Down Dynabeads (ThermoFischer Scientific) were used. Briefly, 
the appropriate protein mixtures were generated by mixing 40 μM of the bait protein with 
equimolar amounts of Tse8-HA-Strep (Tsi8 bait) or 15-fold molar excess of Tse8-HA-Strep 
(GatCAB bait); a condition containing solely the same amount of Tse8-HA-Strep was also 
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tested as a negative binding control. Mixtures were added to a 25 μL bed of Dynabeads and 
incubated at 25 °C with agitation for 1 h, before the beads were washed 8x with 800 μL 
of wash buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.01% Tween 20) and resuspended in 
elution buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.01% Tween 20, 200 mM imidazole).
For pull-down experiments using purified GatCB and cell lysates containing GatA-V5 and 
Tse8-HA-StrepII, 150 OD600 units of cells expressing GatA-V5 and Tse8-HA-StrepII were 
resuspended in binding buffer (20 mM Tris pH 7.5, 100 mM NaCl, 10% (v/v) glycerol 
and 3% (w/v) bovine serum albumin) and lysed by sonication. Pull-downs were performed 
by adding a total volume of 6 mL of cell lysate (3 mL GatA-V5 lysate mixed with 3 mL 
binding buffer or 3 mL GatA-V5 lysate mixed with 3 mL Tse8-HA-StrepII lysate) to a 25 
μL bed of His-Tag Isolation & Pull Down Dynabeads (ThermoFischer Scientific) loaded 
with 40 μg of purified GatCB. Mixtures were incubated at 25 °C with agitation for 1 h 
before the beads were washed 8x with 800 μL of wash buffer (50 mM Tris pH 7.5, 150 mM 
NaCl, 0.01% Tween 20) and resuspended in elution buffer (50 mM Tris pH 7.5, 150 mM 
NaCl, 0.01% Tween 20, 200 mM imidazole).
For all experiments, eluted samples were denatured in 4 x Laemmli buffer and subjected 
to western blotting as described above. Anti-V5 (1:5000 Invitrogen), anti-HA (1:5000 
Biolegend) or anti-His (1:1000 Sigma) primary antibodies were used along with an 
anti-mouse secondary (1:5000 Sigma). For detection of StrepII tags a Strep-Tactin HRP 
conjugate was used (1:3000 IBA Lifesciences). Quantification of Western blot bands was 
performed using the Gel Analyzer plugin in ImageJ51.
Whole-cell glutaminase assays
The whole-cell glutaminase activity was measured as described previously52 with some 
modifications as follows. E. coli B834 cells containing empty vector, gatA or tse8 in pET41a 
were grown to OD600 ~ 0.6 when expression was induced by addition of IPTG (0.5 mM) and 
grown at 18 °C for 16 h. Cells pellets equivalent to 45 OD600 units were washed in sodium 
acetate solution (sodium acetate (100 mM, pH 6), L-glutamine (20 mM)) and resuspended in 
a final volume of 600 μL sodium acetate solution, and incubated at 37 °C for 30 min. 20 μL 
of cells were retained and serially diluted to quantify the CFUs present. The remaining cell 
volume was then lysed by heating at 99 °C for 3 min. Once cooled to room temperature 100 
μL of cell lysate was added to 2 mL of glutamate dehydrogenase solution (sodium acetate 
(10 mm), NAD+ (4 mM), hydroxylamine HCl (400 mM), 30 U of glutamate dehydrogenase 
(GDH) enzyme (Sigma) in potassium phosphate buffer (100 mM, pH 7.2)) and incubated at 
60 °C for 60 min. 150 μL of the reaction was added to a 96 well clear plate and the relative 
accumulation of NADPH was calculated using the measured absorbance at 340 nm.
Expression and purification of Tse8 used for activity measurements
The pET41a::GST-TEV-Tse8 vector coding for P. aeruginosa 
Tse8 was obtained by FastCloning53 using pET41a:GST-Tse8 
(see Supplementary Table 2) as template. This construct was 
subcloned using the forward primer 5′-AACCTGTATTTTCAGGGCGGATCC 
ATCGAGGTCACCGAGGTTTCCATCG-3′ and reverse primer 5′-CCTGAAAATACAGG 
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TTTTCGGTACCCAGATCTGGGCTGTCCATGTGCTGG-3′ in order to exchange the 
Human Rhinovirus (HRV) 3C cleavage site (LEVLFQ/GP) with a TEV protease cleavage 
site (ENLYFQ/G). The resulting construct includes (i) a 651-nucleotide sequence encoding 
a N-terminal GST tag, (ii) an 18-nucleotide sequence encoding a 6x histidine tag, (iii) a 
45-nucleotide sequence encoding a S15 tag and a 21-nucleotide sequence encoding the 
optimal tobacco etch virus (TEV) protease cleavage site Glu-Asn-Leu-Tyr-Phe-Gln-Gly 
(Extended Fig. 5). For protein expression, E. coli BL21(DE3) cells were transformed 
with the pET41a::GST-TEV-Tse8 plasmid and grown in 2xYT (Yeast Extract Tryptone) 
medium (supplemented with 50 μg/ml kanamycin) at 37 °C. When the culture reached 
an OD600 value of 0.7, Tse8 expression was induced by adding 1 mM isopropyl β-D-1­
thiogalactopyranoside (IPTG) and the temperature was dropped to 18°C. After 18 hr, cells 
were harvested and frozen for later use.
For protein purification, each 1 L pellet was resuspended in 50 ml of 50 mM Tris-HCl pH 
8, 500 mM NaCl, 20 mM imidazole, 0.5 mM EDTA and 2 μL of benzonase endonuclease 
(without addition of protease inhibitors). Cells were then disrupted by sonication and the 
suspension was centrifuged for 40 mins at 56,000 g. The supernatant was filtered with a 
0.2 μm syringe filter and subjected to immobilized metal affinity chromatography using a 
1 ml HisTrap HP column (GE Healthcare), on a fast protein liquid chromatography system 
(ÄKTA FPLC; GE Healthcare) equilibrated with 5 ml of 50 mM Tris-HCl pH 8, 500 mM 
NaCl and 20 mM imidazole (buffer A). The column was washed with buffer A at 1 ml/min 
until no absorbance at 280 nm was detected. Elution was performed with a linear gradient 
between 0-50% of 50 mM Tris-HCl pH 8, 500 mM NaCl and 500 mM imidazole in 30 
mL and at 1 ml/min. Fractions containing GST-TEV-Tse8 fusion protein were pooled and 
protein concentration was measured. The cleavage of the GST-His-S15 tag was performed 
with TEV protease (1 mg per 10 milligrams of protein) overnight at 18 °C in buffer 50 
mM Tris–HCl pH 7.5, 2 mM DTT, at a protein concentration between 0.3-0.5 mg/mL. The 
cleaved Tse8, non-cleaved Tse8 and TEV protease were collected, filtered and applied onto 
a HisTrap HP column (5 ml; GE Healthcare) equilibrated with 25 ml of 50 mM Tris-HCl pH 
7.5. The cleaved Tse8 was eluted in the flow-through and applied onto a Mono Q column of 
5 mL (GE Healthcare) equilibrated with 25 ml of 50 mM Tris-HCl pH 7.5. The protein was 
eluted in a single step using 500 mM NaCl in 50 mM Tris-HCl pH 7.5. The Tse8 protein 
was dialyzed with 20 mM sodium phosphate buffer pH 7.6 and concentrated using Centricon 
centrifugal filter units of 30 kDa molecular mass cut-off (Millipore) to a final concentration 
of 5 mg/mL for enzymatic assays. The purity of the protein was verified by SDS-PAGE 
(Extended Data Fig. 5) and protein integrity was evaluated following desalting with stage-tip 
C4 microcolumns (Zip-tip, Millipore) by electrospray ionization mass spectrometry (ESI­
MS). The sampling cone energy was set at 35 V. The m/z data were then deconvoluted 
into MS-data using the MaxEnt software (MaxEnt Solutions Ltd, Cambridge, UK) with a 
resolution of the output mass of 0.5 Da/channel and Uniform Gaussian Damage Model at the 
half height of 0.5 Da. The analysis indicates that 90% of the protein sample corresponds to 
the expected Tse8 molecular weight (60,564 Da; Extended Data Fig. 5).
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Tse8 substrate activity assays
Putative Tse8 substrates were selected based on the predicted GatA and PAM homology. 
Thus, the capacity of Tse8 to hydrolyse carbon-nitrogen bonds was analysed by mass 
spectrometry (MS) using as putative substrates the free amino acid glutamine and the C­
terminally amidated peptide epinecidin-1 (sequence: GFIFHIIKGLFHAGKMIHGLV-NH2) 
(Bachem AG). Glutamine (10 mM) was incubated with 2 μM of freshly purified Tse8. 
Reactions were carried out in two different buffers to test the possible effect of pH; one 
set of reactions was carried out in 10 mM sodium phosphate buffer (pH 7.6) and another 
set of reactions was carried out in 20 mM Tris-HCl buffer (pH 8.3). For epinecidin-1, 
5 μM of freshly-purified Tse8 or the positive control protein Pam (purified as described 
previously54), were incubated with 50 μM of putative substrate in 10 mM sodium phosphate 
buffer (pH 7.2); control reactions, lacking Tse8 or Pam, were also tested. Reactions were 
incubated overnight at 30 °C, followed by MS analysis. For full details on the MS analysis 
see the relevant section below for use of epinecidin-1 or glutamine as a substrate.
Mass spectrometry analysis of Tse8/Pam enzymatic assays using epinecidin-1 as a 
substrate
Samples were desalted and peptides were isolated using stage-tip C18 microcolumns (Zip­
tip, Millipore) and further resuspended in 0.1% formic acid prior to MS analysis. Peptide 
separation was performed on a nanoACQUITY UPLC System (Waters) on-line connected 
to an LTQ Orbitrap XL mass spectrometer (Thermo Electron). An aliquot of each sample 
was loaded onto a Symmetry 300 C18 UPLC Trap column (180 μm x 20 mm, 5 μm 
(Waters)). The precolumn was connected to a BEH130 C18 column (75 μm x 200 mm, 1.7 
μm (Waters), and equilibrated in 3% acetonitrile and 0.1% FA. Peptides were eluted directly 
into an LTQ Orbitrap XL mass spectrometer (Thermo Finnigan) through a nanoelectrospray 
capillary source (Proxeon Biosystems), at 300 nl/min and using a 120 mins linear gradient of 
3-50% acetonitrile. The mass spectrometer automatically switched between MS and MS/MS 
acquisition in DDA mode. Full MS scan survey spectra (m/z 400-2000) were acquired 
in the orbitrap with mass resolution of 30,000 at m/z 400. After each survey scan, the 
six most intense ions above 1,000 counts were sequentially subjected to collision-induced 
dissociation (CID) in the linear ion trap. Precursors with charge states of 2 and 3 were 
specifically selected for CID. Peptides were excluded from further analysis during 60 s using 
the dynamic exclusion feature. RAW files were searched with the Mascot search engine 
(www.matrixscience.com) through Proteome Discoverer v1.4 (Thermo) against a FASTA 
database containing the protein and peptide sequences of interest, together with a Pichia 
pastoris database from Uniprot/Swissprot as a background. Search parameters were: 10 ppm 
peptide mass tolerance, 0.5 Da fragment mass tolerance, carbamydomethylation of cysteines 
as fixed modification, and oxidation of methionine, amidation and deamidation of protein 
C-terminus as variable modifications. Only highly reliable hits (p<0.01) were considered.
Mass spectrometry analysis of Tse8 enzymatic assay using glutamine as substrate
Overnight incubations were quenched by addition of 150 μL 20% acetonitrile (MeCN). 
Controls for the experiment were prepared by first adding MeCN to the reaction blank and 
subsequently adding enzyme. In order to determine LC-MS performance, 100 μM stock 
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solutions of glutamine substrate in 2:3 water/MeCN were injected before the experimental 
samples. Quenched incubations and controls were shaken in the tubes for 30 mins at 
4°C and 1,000 g. Next, samples were centrifuged for 30 mins at 4°C and 25,000 g. The 
resulting solutions were immediately injected in the LC-MS. Samples were measured with 
a UPLC system (Acquity, Waters Inc., Manchester, UK) coupled to a Time of Flight mass 
spectrometer (ToF MS, SYNAPT G2, Waters Inc.). A 2.1 x 100 mm, 1.7 μm BEH amide 
column (Waters Inc.), thermostated at 40 °C, was used to separate the analytes before 
entering the MS. Mobile phase solvent A (aqueous phase) consisted of 99.5% water, 0.5% 
formic acid and 20 mM ammonium formate while solvent B (organic phase) consisted of 
29.5% water, 70% MeCN, 0.5% formic acid and 1 mM ammonium formate. In order to 
obtain a good separation of the analytes the following gradient was used: from 5% A to 50% 
A in 2.4 mins in curved gradient (#8, as defined by Waters), from 50% A to 99.9% A in 0.2 
mins constant at 99.9% A for 1.2 mins, back to 5% A in 0.2 mins. The flow rate was 0.250 
mL/min and the injection volume was 2 μL. The MS was operated in positive (ESI+) and 
negative (ESI-) electrospray ionization in full scan mode. The cone voltage was 25 V and 
capillary voltage was 250 V for ESI+ and 500 V for ESI-. Source temperature was set to 
120 °C and capillary temperature to 450 °C. The flow of the cone and desolvation gas (both 
nitrogen) were set to 5 L/h and 600 L/h, respectively. A 2 ng/mL leucine-enkephalin solution 
in water/acetonitrile/formic acid (49.9/50/0.1% (v/v/v)) was infused at 10 μL/min and used 
for a lock mass which was measured each 36 seconds for 0.5 seconds. Spectral peaks were 
automatically corrected for deviations in the lock mass.
Bioinformatics analysis of prokaryotic organisms encoding AsnS and GlnS
Escherichia coli AsnS and GlnS protein sequences were interrogated against the National 
Center for Biotechnology Information (NCBI) collection of non-redundant protein 
sequences of bacteria and archaea (non-redundant Microbial proteins, update: 2017/11/29) 
using the pBLAST search engine. The search was further restricted for non-redundant 
RefSeq proteins, with a 20,000-hit limit, the BLOSUM62 matrix scoring function and 
an Expect threshold value (E-value) of 1e-5. Hits were selected if sequence identity was 
above 50% with respect to the query sequences and those associated with bacterial species 
Agrobacterium tumefaciens, Escherichia coli and Pseudomonas aeruginosa were extracted 
(Supplementary Table 4).
Bioinformatics analysis of prokaryotic organisms predicted to encode the 
amidotransferase GatCAB complex
A none-exhaustive search for organisms encoding GatCAB was carried out using the 
National Center for Biotechnology Information (NCBI) database. Pseudomonas aeruginosa 
GatA and GatB protein sequences were interrogated against the NCBI collection of 
non-redundant protein sequences of bacteria and archaea (non-redundant Microbial 
proteins, update: 2017/11/29) using the pBLAST search engine. The search was further 
restricted for non-redundant RefSeq proteins, with a 20,000-hit limit, BLOSUM62 matrix 
scoring function and an Expect threshold value (E-value) of 1e-5. Hits were selected if 
annotated as Asp-tRNA(Asn)/Glu-tRNA(Gln) amidotransferase subunits, and the results for 
Agrobacterium tumefaciens, Escherichia coli and Pseudomonas aeruginosa were extracted 
(Supplementary Table 4).
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Statistical analyses were performed using GraphPad Prism version 9 and are detailed in the 
figure legends.
Extended Data
Extended data Fig. 1. 
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Extended data Fig. 2. 
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Extended data Fig. 3. 
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Extended data Fig. 4. 
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Extended data Fig. 5. 
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Extended data Fig. 6. 
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Extended data Fig. 7. 
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Extended data Fig. 8. 
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Extended data Fig. 9. 
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Extended data Fig. 10. 
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Tse8-Tsi8 is a H1-T6SS toxin-immunity pair.
a-b, Expression of Tse8 (either HA tagged or untagged) in PAKΔretSΔtsei8 is toxic 
when expressed in trans from pMMB67HE ((-) no induction; (+) with induction) (a) or 
when delivered by the H1-T6SS into a recipient strain lacking tsi8 (b). c-d, Tsi8 can 
rescue Tse8 toxicity in competition assays with donors PAKΔretS or PAKΔretSΔH1 and 
recipient PAKΔretSΔtsei8 expressing either pJN105 or pJN:tsi8 (c) and in growth assays 
with PAKΔretSΔtsei8 expressing pMMB:tse8 or pJN:tsi8 (d). e, Bacterial-Two-Hybrid 
(BTH) assays were used to quantify the level of interaction between Tse8 and Tsi8 with 
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β-galactosidase activity assays performed on the cell lysates of each interaction pair. 
f, Tse8-HA-Strep interacts directly and specifically with Tsi8-His. Proteins were added 
to His-Tag Dynabeads as indicated. Lane 1: Tsi8-His (as bait) interacts with Tse8-HA­
Strep. Lane 2: Tse8-HA-Strep alone does not interact with the Dynabeads. Lane 3: Tse8­
HA-Strep does not interact with a different His-tagged bait protein, CcmE. Molecular 
weight markers positions are indicated on the left in kDa. Black vertical lines indicate 
where a lane was removed. Statistical analyses: (a) mean OD600 ± SEM is plotted over 
time from three independent replicates; (b) Mean CFUs/mL ± SEM of recipient cells in 
competition/alone are represented from three independent replicates performed in triplicate 
(n=3). Two-tailed student’s t-test, *** P<0.001; * P<0.05; ns between PAKΔretS and 
PAKΔretSΔH2ΔH3 (P=0.436); (c) Mean CFUs/mL ± SEM of recipient cells in competition/
alone are represented from three independent replicates performed in triplicate (n=3). Two­
tailed student’s t-test, * P<0.05 for each sample to PAKΔretS and ns between PAKΔretSΔH1 
[pJN105] and PAKΔretS [pJN:tsi8] (P=0.598); (d) Mean OD600 ± SEM is plotted over time 
from three independent replicates; (e) Mean ± SEM of three biological replicates performed 
in triplicate (n=3). One-way Anova with Tukey’s multiple comparison post-test, * P<0.05 
compared to the Miller units for T18c + T25 for Zip + Zip, or compared to Tsi8 + T25 and 
T18c + Tse8 for Tsi8 + Tse8; (f) Representative blot from one independent replicate (n=1).
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Figure 2. Tse8 interacts with VgrG1a and does not require putative catalytic residue for toxicity.
a, BTH assays were used to quantify the level of interaction between Tse8 and VgrGs 
with β-galactosidase activity assays performed on the cell lysates of each interaction pair. 
b, Tse8 interacts with VgrG1a in dot blot assays (top panel). Densitometry quantifications 
of Tse8 interactions with respective partners (bottom panel). CcmE-His is used as a non­
specific binding control. c, Tse8 toxicity is not dependent on the conserved putative catalytic 
residue S186. Competition assays were performed with donors PAKΔretS, PAKΔretSΔH1, 
PAKΔretS::tse8S186A or PAKΔretSΔH1::tse8S186A and recipient PAKΔretSΔtsei8::lacZ. 
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Statistical analyses: (a) Mean ± SEM of three biological replicates performed in triplicate 
(n=3). One-way Anova with Tukey’s multiple comparison post-test, * P<0.05 compared 
to the Miller units for each of VgrG1a, VgrG1b, VgrG1c and Tse8 with the respective 
T18c or T25 partner. (b) Densitometry measurements normalized to the control and 
represented as the Mean ± SEM from three independent replicates (n=3). Two-tailed 
student’s t-test, ** P<0.005 compared to control; ns between control and VgrG1b (P=0.169), 
VgrG1c (P=0.067) and CcmE (P=0.159). (c) Mean CFUs/mL ± SEM of recovered 
recipient are represented from three independent replicates performed in triplicate (n=3). 
Two-tailed student’s t-test, * P<0.05 for PAKΔretS compared to PAKΔretSΔH1 and 
PAKΔretSΔH1::tse8S186A; ns between PAKΔretS and PAKΔretS::tse8S186A (P=0.226).
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Figure 3. Tse8 targets the transamidosome.
a-c, Tse8 is only toxic in bacteria which rely on the transamidosome for protein synthesis. 
Expression of Tse8 in A. tumefaciens is toxic but can be rescued by coexpression of Tsi8 
((-) no induction; (+) with induction) (a). Expression of Tse8 in E. coli is not toxic ((-) 
no induction; (+) with induction) (b), despite Tse8 being expressed (c). d-e, Proteins were 
added to His-Tag Dynabeads as indicated. d, Left panel, lane 1: His-GatB (as bait) interacts 
with GatC-HA and GatA-V5. Left panel, lane 2: Tse8 HA-Strep interacts with the GatCAB 
complex, but does not displace GatA-V5, even at a 15-fold molar excess. Right panel, 
Nolan et al. Page 36













lane 1: Tse8-HA-Strep alone does not interact with the Dynabeads. Right panel, lane 2: 
Tse8-HA-Strep does not interact with a different His-tagged bait protein, CcmE. e, Left 
panel, lane 1: His-GatB (as bait) interacts with GatC-HA and GatA-V5. Left panel, lane 
2: The presence of Tse8-HA-Strep leads to drastic increase of the amount of GatA-V5 
interacting with His-GatB and GatC-HA. Right panel, lane 1: GatA-V5 alone does not 
interact with the Dynabeads. Right panel, lane 2: GatA-V5 does not interact with a different 
His-tagged bait protein, CcmE. f, Quantification of the amount of GatA-V5 bound to His­
GatB and GatC-HA in the presence or absence of Tse8-HA-Strep by densitometry. For 
panels (c-e) molecular weight markers positions are indicated on the left in kDa. Statistical 
analyses: (a-b) Mean OD600 ± SD is plotted over time from three independent replicates; (c) 
Representative blot from three independent replicates (n=3); (d) Representative blots from 
one independent replicate (n=1); (e) Representative blots from three independent replicates 
(n=3) for the left panel and one independent replicate (n=1) for the right panel; (f) Mean 
densitometry ± SEM from three independent replicates (n=3). Two-tailed student’s t-test, 
*** P<0.001 for GatBC+GatA compared to GatBC+GatA+Tse8.
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Figure 4. Tse8 impacts on protein synthesis in vivo.
a, Asn tRNA synthase (asnS) can rescue Tse8 toxicity. Competition assays were performed 
with donors PAKΔretS or PAKΔretSΔH1 and recipient PAKΔretSΔtsei8 expressing either 
pJN105 or pJN:asnS. b, Cells expressing Tse8 produce less sfGfp/total cells compared 
to an empty vector control. This effect can be rescued by expression of Tsi8 or AsnS. 
sfGfp levels normalised to total cells (measured by OD600) were monitored over time in 
PAKΔretSΔtsei8 with sfGFP expressed from the vacant Tn7 chromosomal site in cells 
containing the indicated plasmids ((+) with induction). Statistical analyses: (a) Mean 
CFUs/mL ± SEM of recipient cells in competition/alone are represented from represented 
from three independent replicates performed in triplicate (n=3). Two-tailed student’s t-test, 
* P<0.05; ns for PAKΔretSΔH1 [pJN105] vs PAKΔretS [pJN:asnS] (P=0.687) or vs 
PAKΔretSΔH1 [pJN:asnS] (P=0.631). (b) Mean fluorescent AU/OD600 ± SEM is plotted 
over time from three independent replicates performed in 8 technical replicates (n=3).
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Table 1
TraDIS allows identification of known and putative previously unidentified H1-T6SS 
immunity genes.
Immunity gene PAK/PA number Immunity Toxin Log fold change* Toxin activity/target
PAKAF_RS16410/PA1845 tsi1 tse1 -2.30 Amidase/peptidoglycan
PAKAF_RS11975/PA2703 tsi2 tse2 -7.30 Unknown cytoplasmic target
PAKAF_RS07460/PA3485 tsi3 tse3 -1.28 Muramidase/peptidoglycan
PAKAF_RS11540/PA2775 tsi4 tse4 -7.30 Unknown periplasmic target
PAKAF_RS12070/PA2683.1 tsi5 tse5 -7.02 Unknown periplasmic target
PAKAF_RS22000/PA0802 PA0802 PA0801 -6.60 Putative M4 peptidase regulator
PAKAF_RS11515/PA2779 PA2279 PA2778 -5.50 Putative C39 peptidase
PAKAF_RS08570/PA3274 PA3274 PA3272 -4.70 Putative nucleoside triphosphate hydrolase
PAKAF_RS03995/PA4164 tsi8 tse8 (PA4163) -3.30 Putative amidase
*
Log fold change compared to normalized levels of insertions in T6SS inactive and T6SS active libraries
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